Inderal LA is a brand-name medication that contains propranolol as its active ingredient. Propranolol is a non-selective beta-adrenergic blocker used to treat a variety of cardiovascular and neurologic conditions. The medication is supplied as a pill (extended-release capsule) in a 40 mg strength and is available only with a prescription in Hong Kong. It is marketed by Novartis and is regulated by the Hong Kong Department of Health.
Propranolol blocks beta-1 and beta-2 adrenergic receptors, preventing the hormone epinephrine (adrenaline) from binding to these receptors. By doing so, it:
The extended-release (LA = Long-Acting) formulation releases propranolol gradually over 12-24 hours, providing more consistent blood levels compared with immediate-release tablets. This results in smoother control of heart rate and blood pressure and allows once-daily dosing for many patients.
Inderal LA is approved for the following indications in Hong Kong, mirroring approvals by major regulatory agencies such as the FDA and EMA:
These uses are based on clinical trials and long-term experience demonstrating that propranolol improves symptom control and reduces cardiovascular risk in the listed patient groups.
Evidence from peer-reviewed studies supports several off-label uses of propranolol, although they are not formally approved in Hong Kong:
Off-label use requires medical supervision and individualized risk assessment.
If any of these serious symptoms occur, seek medical attention promptly.
Patients should provide a full medication list, including over-the-counter products and herbal supplements, to their prescriber.
This article provides educational information about Inderal LA and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Propranolol can worsen bronchospasm in patients with active asthma. It is absolutely contraindicated in severe asthma and should be used only with extreme caution in mild cases, under close medical supervision.
Inderal LA is an extended-release formulation that provides a steady release of propranolol over 12-24 hours, allowing once-daily dosing. Immediate-release tablets release the drug quickly and often require multiple daily doses.
Propranolol is not a prohibited substance on most standard workplace or athletic drug-testing panels, but some sports organisations list beta-blockers as banned for certain events. Check the specific regulations of your employer or sporting body.
Yes, but carry the prescription label and a copy of the prescription. Some countries may require documentation for controlled or prescription medications, so keep the medication in its original container.
Cold extremities are a common side effect due to reduced blood flow. If the sensation is mild, it often improves over time. If it becomes painful or interferes with daily activities, discuss dose adjustment with your clinician.
No specific foods are contraindicated, but large meals can delay absorption slightly. Consistency is key: take the medication at the same time each day, with or without food, as directed by your provider.
Propranolol is approved for migraine prophylaxis in adults and is sometimes prescribed off-label for adolescents. Use in teenagers should be guided by a paediatric neurologist or physician experienced in migraine management.
Blood-pressure reduction may be observed within a few days, but the full therapeutic effect often develops over 2-4 weeks as steady-state drug levels are reached.
Many cough suppressants contain decongestants (e.g., pseudoephedrine) that can raise blood pressure and counteract beta-blocker effects. Consult a pharmacist before adding such products.
Brand-name Inderal LA generally costs more than locally available generic propranolol tablets of the same strength. Prices vary among pharmacies and may be reduced through health-insurance coverage or government subsidy schemes.
